Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
Boston Healthcare grows to meet increasing global demand for health economics and market access support
BOSTON, Oct. 28 /PRNewswire/ -- Boston Healthcare Associates, Inc. today
announced the appointment of Adam Barak as Vice President.
Mr. Barak brings 16 years of pricing and reimbursement experience,
including the development of global pricing and reimbursement strategies for
drugs, medical devices, and diagnostics in a wide range of therapeutic areas
including oncology, pulmonary medicine, gastroenterology, cardiovascular
medicine, neurology, and critical care.
"Adam's appointment demonstrates Boston Healthcare's continued commitment
to expanding the scope and reach of our services," said Joseph Ferrara,
President of Boston Healthcare. "His wealth of experience in pricing and
reimbursement will strengthen our position internationally, and provide the
expertise and leadership we need to serve our clients more effectively
worldwide. Adam is a strong addition to the executive management team and an
asset to our global strategy."
Mr. Barak joined GlaxoWellcome's International Pricing & Reimbursement
division in 1996. In 1997, Mr. Barak became Head of European Pricing,
managing the regional function and developing international pricing strategies
for four of the seven GlaxoWellcome therapy areas, including European pricing
strategies for CNS, cardiovascular, oncology, anesthesiology and diabetes
drugs. In 2001, Mr. Barak joined Oxford GlycoSciences as International
Pricing and Reimbursement Manager, developing global pricing, reimbursement,
and market access strategy for Zavesca, the company's first pharmaceutical
launch. In 2002, Mr. Barak established his own consultancy, ABPPC Ltd, and
formed a global network of consultants that provide the international
pharmaceutical and health care community with specialized support for pricing,
reimbursement, and market access. The network covers 22 countries, and is
represented by Boston Healthcare in the UK and US.
About Boston Healthcare
Boston Healthcare assists emerging and established biopharmaceutical,
medical device and diagnostic companies in gaining a competitive advantage in
the health care marketplace by helping them unlock the value of innovative
drugs, devices, and diagnostics. These companies rely on Boston Healthcare to
create opportunities, navigate complexity, grow their businesses, and achieve
objectives through reimbursement, business development, and market strategies.
Clients draw on Boston Healthcare's unique approach to gain a real-world edge
in a highly competitive health care environment.
